Catalyst Wire Dossier Catalyst Wire Dossier

Follitropin alfa/Lutropin alfa

recombinant FSH and recombinant LH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Follitropin alfa/Lutropin alfa, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) [Phase 3]

See pricing